Updates

CSRXP APPLAUDS INCLUSION OF CREATES IN SPENDING DEAL; URGES CONGRESS TO KEEP WORKING TO HOLD BIG PHARMA ACCOUNTABLE, LOWER Rx PRICES

Dec 16, 2019

Passage of Bipartisan, Market-based CREATES Act Will Be A First Step in the Read More

Big Pharma’s Price-Gouging and Anti-Competitive Tactics Drive Increased Rx Spending

Dec 13, 2019

CMS Report Demonstrates Impact of Out-of-Control Launch Prices and Tactics Read More

CSRXP: THE HOUSE HAS ACTED, TIME FOR SENATE TO DO ITS JOB

Dec 12, 2019

Passage of HR3 Adds to Momentum to Hold Big Pharma Accountable; Now Congress Read More

CSRXP APPLAUDS USMCA CHANGES TO PUT AMERICAN PATIENTS FIRST

Dec 10, 2019

Revisions to Historic Trade Deal Remove Big Pharma Carveout Washington Read More

CSRXP ANALYSIS: BIG PHARMA SPENT TAX WINDFALL ON PROFITS, NOT R&D

Dec 10, 2019

Corporate Filings Show Drug Makers Boosted Payouts for Shareholders 17 Times Read More

BIG PHARMA WATCH: NEW STUDY FINDS PRICE HIKES DRIVEN BY QUEST FOR HIGHER PROFITS, NOT R&D

Dec 4, 2019

Analysis of Multiple Sclerosis Drug Pricing Undercuts Drug Makers’ Bogus Read More

ICYMI: Political Courage Needed to Deliver on Drug Prices

Nov 25, 2019

Political Courage Needed to Deliver on Drug Prices By Lauren Aronson Real Read More

CSRXP SENATE BATTLEGROUND POLL: VOTERS BACK GRASSLEY-WYDEN, DEMAND ACTION TO HOLD BIG PHARMA ACCOUNTABLE

Nov 22, 2019

Survey Finds Overwhelming Majorities of Swing State Voters Blame Drug Makers Read More

ICYMI: GALLUP FINDS NEARLY 58 MILLION AMERICANS UNABLE TO AFFORD THEIR PRESCRIPTION DRUGS, UP FOUR PERCENT FROM JANUARY

Nov 13, 2019

Nine in Ten Surveyed Adults Believe Rx Prices “Much Higher” Or “Somewhat Read More

SECOND OPINION: BIG PHARMA SQUARELY TO BLAME FOR RISING MEDICARE PREMIUMS

Nov 12, 2019

Drug Makers Cry ‘False Narrative’ Over Latest Repot Highlighting Toll of Read More

Q3 Earnings: Big Pharma Keeps The Good Times Rolling While Hiking Prices

Nov 7, 2019

Q3 Earnings: Big Pharma Keeps The Good Times Rolling While Hiking Prices Top Read More

AMERICANS AGREE: CONGRESS MUST ACT TO HOLD BIG PHARMA ACCOUNTABLE AND LOWER DRUG PRICES

Nov 4, 2019

Solutions to Reform Medicare Part D, Increase Competition and Boost Read More